Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 148

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 148
---
4 5,991 Other comprehensive income (loss)— — — — 1,177 (6)1,171 Noncontrolling interests adjustment— — — — — 14 14 Repurchase and retirement of common stock, including excise tax(5.8)— (217)(2,481)— — (2,698)Dividends and dividend equivalents— — — (1,404)— — (1,404)Issuance of common stock under employee stock plans, net of related tax benefits0.9 — 342 — — — 342 Convertible debenture repurchases and conversions— — (341)— — — (341)December 31, 2023233.1 2.0 8,868.0 31,749.0 (1,313.0)99.0 39,405.0 Net income (loss)— — — 5,980 — (9)5,971 Other comprehensive income (loss)— — — — 166 (6)160 Noncontrolling interests adjustment— — — — — 27 27 Repurchase and retirement of common stock, including excise tax(6.7)— (262)(2,662)— — (2,924)Dividends and dividend equivalents— — — (1,518)— — (1,518)Issuance of common stock under employee stock plans, net of related tax benefits1.1 — 305 — — — 305 December 31, 2024227.5 $2 $8,911 $33,549 $(1,147)$111 $41,426 

See accompanying notes.

 -74-

Elevance Health, Inc.

Notes to Consolidated Financial Statements

December 31, 2024 

(In Millions, Except Per Share Data or As Otherwise Stated Herein)

1. Organization 

References to the terms “we,” “our,” “us” or “Elevance Health” used throughout these Notes to Consolidated Financial Statements refer to Elevance Health, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries. References to the “states” include the District of Columbia and Puerto Rico, unless the